EUVIMEDEUVIMED entdecken
Korrektur

Corrigendum to “Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy” [Acta Biomaterialia 162 (2023) 98–109]

Linzhuo Huang, Rui Xu, Weirong Li, Li Lv, Chunhao Lin, Xianzhu Yang, Yandan Yao, Phei Er Saw, Xiaoding Xu

Acta Biomaterialia · 2026-01 · 209 · 638-639

DOI: 10.1016/j.actbio.2025.11.035 ↗

Kurz gefasst

Korrektur in der Zeitschrift Acta Biomaterialia, 2026-01. Verfasst von Linzhuo Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Y…. Gefördert von: Natural Science Foundation of Guangdong Province, Guangzhou Municipal Science and Technology Bureau, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, PR China; Nanhai Translational I…
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, PR China; Breast Tumor Center, S…
  • School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, PR China.

Förderung

  • Natural Science Foundation of Guangdong Province
  • Guangzhou Municipal Science and Technology Bureau
  • National Natural Science Foundation of China
  • Guangdong Provincial Department of Science and Technology
  • International Science and Technology Cooperation Programme
  • Recruitment Program of Global Experts

Zitieren

APA

Huang, L., Xu, R., Li, W., Lv, L., Lin, C., Yang, X., Yao, Y., Saw, P. E., & Xu, X. (2026). Corrigendum to “Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy” [Acta Biomaterialia 162 (2023) 98–109]. Acta Biomaterialia, 209, 638-639. https://doi.org/10.1016/j.actbio.2025.11.035

Vancouver

Huang L, Xu R, Li W, Lv L, Lin C, Yang X, et al. Corrigendum to “Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy” [Acta Biomaterialia 162 (2023) 98–109]. Acta Biomaterialia. 2026;209:638-639. doi:10.1016/j.actbio.2025.11.035

BibTeX
@article{Huang2026,
  author = {Huang, Linzhuo and Xu, Rui and Li, Weirong and Lv, Li and Lin, Chunhao and Yang, Xianzhu and Yao, Yandan and Saw, Phei Er and Xu, Xiaoding},
  title = {Corrigendum to “Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy” [Acta Biomaterialia 162 (2023) 98–109]},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {209},
  pages = {638--639},
  doi = {10.1016/j.actbio.2025.11.035}
}
Kostenlos starten →